Features, pricing, ratings, and pros & cons — compared head-to-head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). OPSWAT MetaDefender Endpoint is a commercial endpoint protection platform tool by OPSWAT. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Mid-market and enterprise security teams that treat removable media and USB devices as a serious attack surface will get immediate value from OPSWAT MetaDefender Endpoint; its 30+ engine multiscanning engine detects 99.2% of malware and the content disarm and reconstruction capability handles 200+ file formats, which matters for organizations that can't afford a single infected USB to bypass traditional perimeter controls. The deep CDR technology with recursive sanitization and air-gapped deployment support address what most endpoint platforms ignore. Skip this if you need integrated threat hunting or behavioral analytics; MetaDefender is tactical hardening for a specific problem, not a replacement for full endpoint detection and response.
Tool that immunizes Windows systems against critical vulnerabilities
Protects endpoints from peripheral and removable media threats with multiscanning
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs OPSWAT MetaDefender Endpoint for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
OPSWAT MetaDefender Endpoint: Protects endpoints from peripheral and removable media threats with multiscanning. built by OPSWAT. Core capabilities include Removable media and USB device access control with security condition enforcement, Multiscanning with 30+ anti-malware engines for 99.2% malware detection, Deep CDR technology supporting 200+ file formats with recursive sanitization..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. OPSWAT MetaDefender Endpoint differentiates with Removable media and USB device access control with security condition enforcement, Multiscanning with 30+ anti-malware engines for 99.2% malware detection, Deep CDR technology supporting 200+ file formats with recursive sanitization.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). OPSWAT MetaDefender Endpoint is developed by OPSWAT. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
360 High-Risk Vulnerability Immunization Tool V2.0 and OPSWAT MetaDefender Endpoint serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox